Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 185

The DOI matches its Crossref record.

Long-Term Outcomes of IgA Nephropathy Presenting with Minimal or No Proteinuria

Open access
Gutiérrez, Eduardo, Zamora, Isabel, Ballarín, José Antonio, Arce, Yolanda, Jiménez, Sara, Quereda, Carlos, Olea, Teresa, Martínez-Ara, Jorge, Segarra, Alfons, Bernis, Carmen, García, Asunción, Goicoechea, Marian, García de Vinuesa, Soledad, Rojas-Rivera, Jorge, Praga, Manuel·2012·Journal of the American Society of Nephrology

Abstract

The long-term outcome of patients with IgA nephropathy who present with normal renal function, microscopic hematuria, and minimal or no proteinuria is not well described. Here, we studied 141 Caucasian patients with biopsy-proven IgA nephropathy who had minor abnormalities at presentation and a median follow-up of 108 months. None of the patients received corticosteroids or immunosuppressants. We reviewed renal biopsies using the Oxford classification criteria. In this sample, 46 (32%) patients had mesangial proliferation, whereas endocapillary proliferation, focal glomerulosclerosis, and tubulointerstitial abnormalities were uncommon. Serum creatinine increases >50% and >100% were observed in five (3.5%) patients and one (0.7%) patient, respectively; no patients developed ESRD. After 10, 15, and 20 years, 96.7%, 91.9%, and 91.9% of patients maintained serum creatinine values less than a 50% increase, respectively. Using Cox proportional hazards regression, the presence of segmental glomerulosclerosis was the only factor that significantly associated with a >50% increase in serum creatinine. Clinical remission occurred in 53 (37.5%) patients after a median of 48 months. Proteinuria>0.5 and >1.0 g/24 h developed in 21 (14.9%) and 6 (4.2%) patients, respectively. Median proteinuria at the end of follow-up was 0.1 g/24 h, with 41 (29.1%) patients having no proteinuria. At presentation, 23 (16.3%) patients were hypertensive compared with 30 (21.3%) patients at the end of follow-up; 59 (41.8%) patients were treated with renin-angiotensin blockers because of hypertension or increasing proteinuria. In summary, the long-term prognosis for Caucasian patients with IgA nephropathy who present with minor urinary abnormalities and normal renal function is excellent.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1681/asn.2012010063

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 185

Metadata

Authors
Gutiérrez, E., Zamora, I., Ballarín, J. A., Arce, Y., Jiménez, S., Quereda, C., Olea, T., Martínez-Ara, J., Segarra, A., Bernis, C., García, A., Goicoechea, M., García de Vinuesa, S., Rojas-Rivera, J., & Praga, M.
Venue
Journal of the American Society of Nephrology
Published
2012-10
Volume
23
Issue
10
Pages
1753-1760
ISSN
1046-6673 (ISSN-L)
OpenAlex
W2125202366
Cited by
185
References
0
FWCI
10.84
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-Term Outcomes of IgA Nephropathy Presenting with Minimal or No Proteinuria. https://app.cochat.ai/papers/10.1681/asn.2012010063
The paper
Gutiérrez, E., Zamora, I., Ballarín, J. A., Arce, Y., Jiménez, S., Quereda, C., Olea, T., Martínez-Ara, J., Segarra, A., Bernis, C., García, A., Goicoechea, M., García de Vinuesa, S., Rojas-Rivera, J., & Praga, M. (2012). Long-Term Outcomes of IgA Nephropathy Presenting with Minimal or No Proteinuria. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2012010063

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.